Literature DB >> 25622111

Adverse cognitive effects of medications: turning attention to reversibility.

Noll L Campbell1, Malaz A Boustani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25622111      PMCID： PMC4346513          DOI： 10.1001/jamainternmed.2014.7667

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  8 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

2.  Use of anticholinergics and the risk of cognitive impairment in an African American population.

Authors:  N L Campbell; M A Boustani; K A Lane; S Gao; H Hendrie; B A Khan; J R Murrell; F W Unverzagt; A Hake; V Smith-Gamble; K Hall
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

3.  Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.

Authors:  Chris Fox; Kathryn Richardson; Ian D Maidment; George M Savva; Fiona E Matthews; David Smithard; Simon Coulton; Cornelius Katona; Malaz A Boustani; Carol Brayne
Journal:  J Am Geriatr Soc       Date:  2011-06-24       Impact factor: 5.562

Review 4.  Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.

Authors:  Chris Fox; Toby Smith; Ian Maidment; Wei-Yee Chan; Nelson Bua; Phyo Kyaw Myint; Malaz Boustani; Chun Shing Kwok; Michelle Glover; Imogen Koopmans; Noll Campbell
Journal:  Age Ageing       Date:  2014-07-19       Impact factor: 10.668

5.  Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.

Authors:  Shelly L Gray; Melissa L Anderson; Sascha Dublin; Joseph T Hanlon; Rebecca Hubbard; Rod Walker; Onchee Yu; Paul K Crane; Eric B Larson
Journal:  JAMA Intern Med       Date:  2015-03       Impact factor: 21.873

6.  2014 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2014-03       Impact factor: 21.566

7.  Long-term anticholinergic use and the aging brain.

Authors:  Xueya Cai; Noll Campbell; Babar Khan; Christopher Callahan; Malaz Boustani
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

8.  Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review.

Authors:  Ronald L Castelino; Sarah N Hilmer; Beata V Bajorek; Prasad Nishtala; Timothy F Chen
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923
  8 in total
  8 in total

1.  Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Authors:  Ariel R Green; Liza M Reifler; Cynthia M Boyd; Linda A Weffald; Elizabeth A Bayliss
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

2.  Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.

Authors:  Noll L Campbell; Anthony J Perkins; Pamela Bradt; Sinem Perk; Ronald C Wielage; Malaz A Boustani; Daniel B Ng
Journal:  Pharmacotherapy       Date:  2016-11-05       Impact factor: 4.705

3.  Use of Bladder Antimuscarinics in Older Adults with Impaired Cognition.

Authors:  Ariel R Green; Jodi Segal; Jing Tian; Esther Oh; David L Roth; Liam Hilson; Jennifer L Dodson; Cynthia M Boyd
Journal:  J Am Geriatr Soc       Date:  2016-11-07       Impact factor: 5.562

4.  Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit.

Authors:  Noll L Campbell; Anthony J Perkins; Babar A Khan; Sujuan Gao; Mark O Farber; Sikandar Khan; Sophia Wang; Malaz A Boustani
Journal:  J Am Geriatr Soc       Date:  2019-01-21       Impact factor: 5.562

5.  Development of video animations to encourage patient-driven deprescribing: A Team Alice Study.

Authors:  Jennifer A Stoll; Molly Ranahan; Michael T Richbart; Mary K Brennan-Taylor; John S Taylor; Laura Brady; Joseph Cal; Andrew Baumgartner; Robert G Wahler; Ranjit Singh
Journal:  Patient Educ Couns       Date:  2021-05-11

6.  The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.

Authors:  E A Bayliss; S M Shetterly; M L Drace; J Norton; A R Green; E Reeve; L A Weffald; L Wright; M L Maciejewski; O C Sheehan; J L Wolff; K S Gleason; C Kraus; M Maiyani; M Du Vall; C M Boyd
Journal:  Trials       Date:  2020-06-18       Impact factor: 2.279

7.  Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.

Authors:  Diana Wucherer; Tilly Eichler; Johannes Hertel; Ingo Kilimann; Steffen Richter; Bernhard Michalowsky; Jochen René Thyrian; Stefan Teipel; Wolfgang Hoffmann
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence.

Authors:  Lotfi Khemiri; Pia Steensland; Joar Guterstam; Örjan de Manzano; Johan Franck; Nitya Jayaram-Lindström
Journal:  Psychopharmacology (Berl)       Date:  2019-10-18       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.